An amphophilic antibiotic with antifungal activity. The antifungal mode of action has been documented through the inhibition of β-glucagon biosythesis through selective blockage of the β-1,3-glucan synthetase reaction. This inhibition of β-1,3-glucan synthetase has also been attributed to Aculeacin A's antibiotic activity to inhibit cell wall synthesis.
1. Mizuno, K., et al. 1977. J. Antibiot. 30: 297-302. PMID: 324959
2. Yamaguchi, H., et al. 1982. J. Antibiot. 35: 210-219. PMID: 7042671
3. Yamaguchi, H., et al. 1985. Microbiol. Immunol. 29: 609-623. PMID: 2935715
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.